Single-nucleotide variants within heart enhancers increase binding affinity and disrupt heart development.
GATA4
affinity-optimizing SNVs
causal enhancer variants
enhanceropathies
enhancers
heart development
low affinity
suboptimal affinity
suboptimization
Journal
Developmental cell
ISSN: 1878-1551
Titre abrégé: Dev Cell
Pays: United States
ID NLM: 101120028
Informations de publication
Date de publication:
06 11 2023
06 11 2023
Historique:
received:
20
12
2022
revised:
07
06
2023
accepted:
20
09
2023
medline:
9
11
2023
pubmed:
18
10
2023
entrez:
17
10
2023
Statut:
ppublish
Résumé
Transcriptional enhancers direct precise gene expression patterns during development and harbor the majority of variants associated with phenotypic diversity, evolutionary adaptations, and disease. Pinpointing which enhancer variants contribute to changes in gene expression and phenotypes is a major challenge. Here, we find that suboptimal or low-affinity binding sites are necessary for precise gene expression during heart development. Single-nucleotide variants (SNVs) can optimize the affinity of ETS binding sites, causing gain-of-function (GOF) gene expression, cell migration defects, and phenotypes as severe as extra beating hearts in the marine chordate Ciona robusta. In human induced pluripotent stem cell (iPSC)-derived cardiomyocytes, a SNV within a human GATA4 enhancer increases ETS binding affinity and causes GOF enhancer activity. The prevalence of suboptimal-affinity sites within enhancers creates a vulnerability whereby affinity-optimizing SNVs can lead to GOF gene expression, changes in cellular identity, and organismal-level phenotypes that could contribute to the evolution of novel traits or diseases.
Identifiants
pubmed: 37848026
pii: S1534-5807(23)00492-6
doi: 10.1016/j.devcel.2023.09.005
pii:
doi:
Substances chimiques
Nucleotides
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
2206-2216.e5Subventions
Organisme : NIGMS NIH HHS
ID : T32 GM133351
Pays : United States
Organisme : NHGRI NIH HHS
ID : DP2 HG010013
Pays : United States
Organisme : NIDA NIH HHS
ID : U01 DA051234
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL107442
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL007444
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM008666
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH113715
Pays : United States
Organisme : NIDA NIH HHS
ID : P50 DA037844
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM127235
Pays : United States
Organisme : NIH HHS
ID : S10 OD026929
Pays : United States
Informations de copyright
Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests The authors declare no competing interests.